Shares of ChronoScale Holdings Corporation rose 16.68%, or $3.29, to close at $23.01 Tuesday, extending a pattern of extreme single-day volatility that has characterized the small, newly formed AI infrastructure company since it emerged from a corporate transformation earlier this year. The specific catalyst behind Tuesday's move had not been publicly confirmed as of publication.

ChronoScale, based in Dallas and trading on the Nasdaq under the ticker CHRN, designs and develops a compute platform intended to support large-scale artificial intelligence workloads, providing dedicated compute environments the company says are engineered for performance, consistency and long-term operational execution. The company in its current form is a recent creation: it was formerly known as Ekso Bionics Holdings, a maker of medical and industrial exoskeleton products, before completing a business combination in February 2026 that transformed it into an AI infrastructure operator through a transaction with Applied Digital Corporation.

Under the terms of that deal, disclosed in SEC filings, a wholly owned subsidiary of Applied Digital's parent company contributed all of the equity in its Cloud business to what was then Ekso Bionics in exchange for roughly 138.2 million newly issued shares of common stock, immediately making Applied Digital's affiliated entity the overwhelmingly dominant shareholder, holding approximately 96% to 97% of the combined company's outstanding shares. Legacy Ekso Bionics shareholders were left holding only about 3% of the newly formed entity. As part of the same transaction, the company changed its name........

© International Business Times